It is an achievement worthy of note and very encouraging.
At this stage of the company growth cycle I believe Admedus/WP is somewhat concerned with being overly transparent around their progress due to the competitive nature of the market. That is also why ADAPT sales are most likely not split by product.
This does suck for us shareholders at the current SP but it's a long game for me so as long as this manifests in revenue/profits I'm not too worried.
While account openings are great, it is revenue growth that will ultimately drive the share price
It is an achievement worthy of note and very encouraging. At...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.56 |
Change
-0.740(5.56%) |
Mkt cap ! $265.4M | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.30 | $12.55 | $359.0K | 27.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 399 | $12.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.78 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |